Tag: Therapeutics

Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M

Healthcare company HRTX recently announced their impressive growth in the fourth quarter of 2025, citing the success of

Is C4 Therapeutics (CCCC) One of the Best Biotech Penny Stocks to Buy According to Analysts?

C4 Therapeutics Inc. (NASDAQ: CCCC) is gaining attention as one of the best biotech penny stocks to buy

Do You Think Beam Therapeutics (BEAM) is an Undervalued Stock?

Contrarius Investment Management, an investment management company, recently released its third-quarter investor letter for the “Contrarius Global Equity

Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company that focuses on developing cell and exosome-based therapeutics for diseases

Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today

A prominent and seasoned company in the healthcare industry appears to be interested in acquiring the biotech firm.

Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger

We have recently featured a piece titled 10 Major Players With Significant Gains; 6 Reach All-Time Highs. Among

Biotech Startup Tahoe Therapeutics Raised $30 Million To Build AI Models Of Living Cells

Tahoe Therapeutics, a biotech startup co-founded by Kevin Shokat, Nima Alidoust, Johnny Yu, and Hani Goodarzi, is making

MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up

Jake Becraft, a former grad student in biological engineering at MIT, had a groundbreaking idea that could revolutionize

UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR)

United Therapeutics Corp. (NASDAQ:UTHR) has been identified as one of the top debt-free stocks to invest in right

Edgewise Therapeutics price target lowered to $35 from $40 at Wedbush

Wedbush analyst Laura Chico recently adjusted the firm's price target on Edgewise Therapeutics (EWTX) from $40 to $35,

Mineralys Therapeutics stock soars on blood pressure drug data

Mineralys Therapeutics, a small drug developer, made a groundbreaking announcement on Monday regarding their experimental drug, lorundrostat. The

Experimental Marburg vaccines, therapeutics headed to Rwanda

Experimental vaccines and therapeutics to combat the deadly Marburg virus have been scheduled to arrive in Rwanda this